Markus W Löffler

30PUBLICATIONS
129CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMedical molecular engineering of nucleic acids and proteinsGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Oct 09, 2025
Exceptional tumor-free survival of a patient with metastatic intrahepatic cholangiocarcinoma after surgery and personalized peptide vaccination: revisiting a striking case.

Ana Maia, Juliane Schuhmacher, Silvio Nadalin

|Aug 31, 2025
HLA Ligand Atlas DIA: extending the benign immunopeptidomics resource with increased sensitivity through data-independent acquisition mass spectrometry.

Leon Bichmann, Ana Marcu, Daniel Johannes Kowalewski

|Nov 26, 2024
First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster.

Meral Esen, Johanna Fischer-Herr, Julian Justin Gabor

|Oct 16, 2024
A multiantigenic Orf virus-based vaccine efficiently protects hamsters and nonhuman primates against SARS-CoV-2.

Alena Reguzova, Melanie Müller, Felix Pagallies

|Jul 29, 2024
Peptide-stimulated T cells bypass immune checkpoint inhibitor resistance and eliminate autologous microsatellite instable colorectal cancer cells.

Sandra Schwarz, Zhaoran Su, Mathias Krohn

|May 23, 2024
naRNA-LL37 composite DAMPs define sterile NETs as self-propagating drivers of inflammation.

Francesca Bork, Carsten L Greve, Christine Youn

Pageof 5

Frequent Collaborators

7 joint publications

Hans-Georg Rammensee

6 joint publications

Can Yurttas

3 joint publications

Annika Nelde

3 joint publications

Cécile Gouttefangeas